News Foley Represents AltheaDx in Acquisition by Castle Biosciences Foley & Lardner LLP announced today that it represented AltheaDx, Inc., a mental health diagnostics…Brandee DiamondApril 27, 2022
Blogs Latin America Venture Investment Sees a Q1 Decline, but Earlier Stage Investment Remains Strong Last year, we saw an incredible amount of investment in Latin American startups, with an…Andre ThiollierApril 22, 2022
News Foley Represents Acrobator Ventures as Lead Investor Funding Round for MiLaboratories Inc. Foley & Lardner LLP represented Amsterdam’s Acrobator Ventures as one of the lead investors in…Louis LehotMarch 25, 2022
Blogs What’s Driving Increased Activity in Secondary Markets for Private Company Stock in 2022 With the turmoil facing public markets in recent months, it’s not a wonder that we…Louis LehotMarch 18, 2022
News Foley Represents NEA in Investment in SafeBase Foley & Lardner LLP recently represented New Enterprise Associates (NEA) in its investment in the…Louis LehotMarch 11, 2022
News Foley Partner Louis Lehot Quoted in Capital.com Article Discussing Crypto Regulation Foley Partner Louis Lehot was quoted in a Capital.com article, “Crypto developers say Biden order will benefit…Louis LehotMarch 9, 2022
News Foley Represents Altis in $7M Seed Funding Round Foley & Lardner recently represented Altis, the world’s first AI personal trainer, in its raise of…Louis LehotMarch 4, 2022
News Foley Partner Louis Lehot Interviewed on Hsu Untied Podcast Discussing His Practice Foley & Lardner LLP Partner Louis Lehot was recently featured on Richard Hsu’s podcast, “Untied,”…Louis LehotMarch 3, 2022
News Foley Partner Louis Lehot Quoted in Crunchbase Discussing SPACs Searching for Targets Foley & Lardner LLP Partner Louis Lehot was quoted in a Crunchbase News article titled, “The Market…Louis LehotMarch 2, 2022
Blogs Venture Capital Boom Article originally published in LatinVex on February 22, 2022. Reprinted with permission. The year of 2021 may…Andre ThiollierFebruary 22, 2022